Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Danielle Boyce is active.

Publication


Featured researches published by Danielle Boyce.


Radiology | 2011

Right and Left Ventricular Myocardial Perfusion Reserves Correlate with Right Ventricular Function and Pulmonary Hemodynamics in Patients with Pulmonary Arterial Hypertension

Jens Vogel-Claussen; Jan Skrok; Monda L. Shehata; Sukhminder Singh; Christopher T. Sibley; Danielle Boyce; Noah Lechtzin; Reda E. Girgis; Steven C. Mathai; Tom Goldstein; Jie Zheng; Joao A.C. Lima; David A. Bluemke; Paul M. Hassoun

PURPOSEnTo evaluate the relationships of right ventricular (RV) and left ventricular (LV) myocardial perfusion reserves with ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension (PAH) by using adenosine stress perfusion cardiac magnetic resonance (MR) imaging.nnnMATERIALS AND METHODSnThis HIPAA-compliant study was institutional review board approved. Twenty-five patients known or suspected to have PAH underwent right heart catheterization and adenosine stress MR imaging on the same day. Sixteen matched healthy control subjects underwent cardiac MR imaging only. RV and LV perfusion values at rest and at adenosine-induced stress were calculated by using the Fermi function model. The MR imaging-derived RV and LV functional data were calculated by using dedicated software. Statistical testing included Kruskal-Wallis tests for continuous data, Spearman rank correlation tests, and multiple linear regression analyses.nnnRESULTSnSeventeen of the 25 patients had PAH: 11 with scleroderma-associated PAH, and six with idiopathic PAH. The remaining eight patients had scleroderma without PAH. The myocardial perfusion reserve indexes (MPRIs) in the PAH group (median RV MPRI, 1.7 [25th-75th percentile range, 1.3-2.0]; median LV MPRI, 1.8 [25th-75th percentile range, 1.6-2.1]) were significantly lower than those in the scleroderma non-PAH (median RV MPRI, 2.5 [25th-75th percentile range, 1.8-3.9] [P = .03]; median LV MPRI, 4.1 [25th-75th percentile range, 2.6-4.8] [P = .0003]) and control (median RV MPRI, 2.9 [25th-75th percentile range, 2.6-3.6] [P < .01]; median LV MPRI, 3.6 [25th-75th percentile range, 2.7-4.1] [P < .01]) groups. There were significant correlations between biventricular MPRI and both mean pulmonary arterial pressure (mPAP) (RV MPRI: ρ = -0.59, Bonferroni P = .036; LV MPRI: ρ = -0.79, Bonferroni P < .002) and RV stroke work index (RV MPRI: ρ = -0.63, Bonferroni P = .01; LV MPRI: ρ = -0.75, Bonferroni P < .002). In linear regression analysis, mPAP and RV ejection fraction were independent predictors of RV MPRI. mPAP was an independent predictor of LV MPRI.nnnCONCLUSIONnBiventricular vasoreactivity is significantly reduced with PAH and inversely correlated with RV workload and ejection fraction, suggesting that reduced myocardial perfusion reserve may contribute to RV dysfunction in patients with PAH.


Pulmonary circulation | 2015

Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis

Celia P. Corona-Villalobos; Ihab R. Kamel; Neda Rastegar; Rachel Damico; Todd M. Kolb; Danielle Boyce; Ala Eddin S. Sager; Jan Skrok; Monda L. Shehata; Jens Vogel-Claussen; David A. Bluemke; Reda E. Girgis; Stephen C. Mathai; Paul M. Hassoun; Stefan L. Zimmerman

We tested the hypothesis that bidimensional measurements of right ventricular (RV) function obtained by cardiac magnetic resonance imaging (CMR) in patients with pulmonary arterial hypertension (PAH) are faster than volumetric measures and highly reproducible, with comparable ability to predict patient survival. CMR-derived tricuspid annular plane systolic excursion (TAPSE), RV fractional shortening (RVFS), RV fractional area change (RVFAC), standard functional and volumetric measures, and ventricular mass index (VMI) were compared with right heart catheterization data. CMR analysis time was recorded. Receiver operating characteristic curves, Kaplan-Meier, Cox proportional hazard (CPH), and Bland-Altman test were used for analysis. Forty-nine subjects with PAH and 18 control subjects were included. TAPSE, RVFS, RVFAC, RV ejection fraction, and VMI correlated significantly with pulmonary vascular resistance and mean pulmonary artery pressure (all P < 0.05). Patients were followed up for a mean (± standard deviation) of 2.5 ± 1.6 years. Kaplan-Meier curves showed that death was strongly associated with TAPSE <18 mm, RVFS <16.7%, and RVFAC <18.8%. In CPH models with TAPSE as dichotomized at 18 mm, TAPSE was significantly associated with risk of death in both unadjusted and adjusted models (hazard ratio, 4.8; 95% confidence interval, 2.0–11.3; P = 0.005 for TAPSE <18 mm). There was high intra- and interobserver agreement. Bidimensional measurements were faster (1.5 ± 0.3 min) than volumetric measures (25 ± 6 min). In conclusion, TAPSE, RVFS, and RVFAC measures are efficient measures of RV function by CMR that demonstrate significant correlation with invasive measures of PAH severity. In patients with PAH, TAPSE, RVFS, and RVFAC have high intra- and interobserver reproducibility and are more rapidly obtained than volumetric measures. TAPSE <18 mm by CMR was strongly and independently associated with survival in PAH.


Journal of Magnetic Resonance Imaging | 2012

Cardiac MRI evaluation of hypertrophic cardiomyopathy: Left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction

Jens Vogel-Claussen; Miguel Santaularia Tomas; Amit Newatia; Danielle Boyce; Aurelio Pinheiro; Roselle Abraham; Theodore P. Abraham; David A. Bluemke

To evaluate if left ventricular outflow tract/aortic valve (LVOT/AO) diameter ratio measured by cardiac magnetic resonance (CMR) imaging is an accurate marker for LVOT obstruction in patients with hypertrophic cardiomyopathy (HCM) compared to Doppler echocardiography.


Journal of Cardiovascular Magnetic Resonance | 2011

Coronary flow reserve correlates with right ventricular dysfunction and predicts right heart failure in patients with pulmonary arterial hypertension

Jan Skrok; Monda L. Shehata; Stephen C. Mathai; Miguel Santaularia Tomas; Sukhminder Singh; Reda E. Girgis; James O. Mudd; Danielle Boyce; Noah Lechtzin; Joao Ac Lima; David A. Bluemke; Paul M. Hassoun; Jens Vogel-Claussen

Figure 1 ROI Placement and Flow-Time-Curves. Phase contract MRI images of the CSF for a patient with scleroderma-associated PAH (mPAP 49 mmHg) during rest (top row: A, B) and adenosine-induced stress (bottom row: D, E). The red ROI is drawn around the coronary sinus, the blue ROI is placed in adjacent myocardium to correct for through-plane motion. The flow-time curves (C, F) demonstrate that net CSF increased only slightly from rest (0.86 ml/min/g) to stress (1.32 ml/min/g), resulting in a CFR of 1.53. Correspondingly, there is only little change in the diameter of and flow signal within the coronary sinus.


american thoracic society international conference | 2009

Survival of Pulmonary Arterial Hypertension Related to Systemic Sclerosis: A Single Center Longitudinal Study.

Aranzazu Campo; Stephen C. Mathai; Ari Zaiman; Hunter C. Champion; T Housten; Danielle Boyce; Noah Lechtzin; Laura K. Hummers; Frederick M. Wigley; Reda E. Girgis; Paul M. Hassoun


american thoracic society international conference | 2009

Depression and Health-Related Quality of Life in Pulmonary Hypertension.

Stephen C. Mathai; Danielle Boyce; Noah Lechtzin; Reda E. Girgis; Paul M. Hassoun


Chest | 2009

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IS A UNIQUE MARKER OF POOR SURVIVAL IN SCLERODERMA-RELATED PULMONARY ARTERIAL HYPERTENSION

Stephen C. Mathai; Monica Bueso; Laura K. Hummers; Danielle Boyce; Noah Lechtzin; Jerome LePavec; Hunter C. Champion; Fredrick M. Wigley; Reda E. Girgis; Paul M. Hassoun


american thoracic society international conference | 2012

Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms Are Associated With Favorable Hemodynamic Indices In Pulmonary Arterial Hypertension

Todd M. Kolb; Danielle Boyce; Nicholas Rafaels; Li Gao; Reda E. Girgis; Ari Zaiman; Stephen C. Mathai; Kathleen C. Barnes; Rachel Damico; Paul M. Hassoun


Archive | 2012

MR Imaging-derived First-Pass Bolus Kinetic Parameters Are Biomarkers for Pulmonary Hemodynamics, Cardiac Function, and Ventricular Remodeling 1

Jan Skrok; Monda L. Shehata; Stephen C. Mathai; Reda E. Girgis; Ari Zaiman; James O. Mudd; Danielle Boyce; Noah Lechtzin; Joao Lima; David A. Bluemke; Paul M. Hassoun; Jens Vogel-Claussen


International Journal of Radiation Oncology Biology Physics | 2012

Cardiac Toxicity is Not Increased 25 Years After Treatment of Early-stage Breast Carcinoma With Mastectomy or Breast Conservation Therapy From the National Cancer Institute Randomized Trial

Charles B. Simone; Christopher T. Sibley; Tu D. Dan; Danielle Boyce; Sharon M. Smith; Marc E. Lippman; Eli Glatstein; David A. Bluemke; Kevin Camphausen; Nicole L. Simone

Collaboration


Dive into the Danielle Boyce's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stephen C. Mathai

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Noah Lechtzin

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ari Zaiman

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

David A. Bluemke

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura K. Hummers

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Jan Skrok

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge